Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-964P is a human pseudogene belonging to the U6 small nuclear RNA gene family. The canonical U6 snRNA is a highly conserved, non-coding RNA that is an integral component of the spliceosome, essential for pre-mRNA splicing in eukaryotic nuclei. However, as a pseudogene, RNU6-964P has sequence similarity to the U6 snRNA gene but is generally non-functional and not transcribed into a product that participates in spliceosome assembly or function. U6 snRNA pseudogenes are common throughout the human genome, contributing to genetic diversity but not directly involved in cellular processes such as signal transduction, cell cycle control, or disease mechanisms. There is no evidence that RNU6-964P acts as a receptor, enzyme, transporter, or is implicated in pathology or drug response, based on current genomic and biomedical databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 964, pseudogene (RNU6-964P).